SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-038742
Filing Date
2024-03-26
Accepted
2024-03-26 08:03:09
Documents
16
Period of Report
2024-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm249787d1_8k.htm   iXBRL 8-K 36125
2 EXHIBIT 4.1 tm249787d1_ex4-1.htm EX-4.1 102660
3 EXHIBIT 4.2 tm249787d1_ex4-2.htm EX-4.2 98116
4 EXHIBIT 10.1 tm249787d1_ex10-1.htm EX-10.1 249318
  Complete submission text file 0001104659-24-038742.txt   776165

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bpth-20240325.xsd EX-101.SCH 3036
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpth-20240325_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpth-20240325_pre.xml EX-101.PRE 22373
19 EXTRACTED XBRL INSTANCE DOCUMENT tm249787d1_8k_htm.xml XML 3619
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 24780969
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)